APA (7th ed.) Citation

Perera-Bel, J., Hutter, B., Heining, C., Fröhlich, M., Fröhling, S., Glimm, H., & Brors, B. (2018). From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards. Genome medicine, 10, . https://doi.org/10.1186/s13073-018-0529-2

Chicago Style (17th ed.) Citation

Perera-Bel, Júlia, Barbara Hutter, Christoph Heining, Martina Fröhlich, Stefan Fröhling, Hanno Glimm, and Benedikt Brors. "From Somatic Variants Towards Precision Oncology: Evidence-driven Reporting of Treatment Options in Molecular Tumor Boards." Genome Medicine 10 (2018). https://doi.org/10.1186/s13073-018-0529-2.

MLA (9th ed.) Citation

Perera-Bel, Júlia, et al. "From Somatic Variants Towards Precision Oncology: Evidence-driven Reporting of Treatment Options in Molecular Tumor Boards." Genome Medicine, vol. 10, 2018, https://doi.org/10.1186/s13073-018-0529-2.